Aeolus Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing a portfolio of novel metalloporphyrins. The firm develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious disease, and diseases of the central nervous system. The company was founded by Brian J. Day in 1994 and is headquartered in Mission Viejo, CA.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company